NAD recommends Nutrition 21 end claims its supplement aids memory
NEW YORK The National Advertising Division of the Council of Better Business Bureaus on Tuesday recommended that Nutrition 21, the marketer of Core4Life Advanced Memory Formula, discontinue with claims that its supplement improves memory.
Specifically, NAD challenged Nutrition 21’s “unqualified claims” that Advanced Memory Formula “Improves Memory & Recall,” “Increases Alertness & Concentration” and “Helps Improve Focus and Vitality.” These claims were not supported by the evidence, NAD asserted, and should be discontinued or modified to more accurately reflect the existing evidence.
Nutrition 21 appreciates “NAD’s careful consideration in making its decision and agrees to take the NAD’s conclusions and recommendations in this matter into account in future advertising of its Core4Life Advanced Memory Formula product,” the company said.
Report says winter weather may cause vitamin D deficiency
MAYWOOD, Ill. According to a review article in Circulation, many people may experience a decrease in vitamin D levels over the winter months, when they are less exposed to sunligh, which can play a role in heart disease.
“Chronic vitamin D deficiency may be a culprit in heart disease, high blood pressure and metabolic syndrome,” said Sue Penckoferstudy author and professor, Marcella Niehoff School of Nursing, Loyola University Chicago, in a press release issued Monday.
The review article cited a number of studies that linked vitamin D deficiency to heart disease. These studies found rates of severe disease or death may be 30 to 50 percent higher among sun-deprived individuals with heart disease.
Penckofer and colleagues concluded that diet alone is not sufficient to manage vitamin D levels. Treatment options to correct this level, such as vitamin D2 or D3, may decrease the risk of severe disease or death from cardiovascular disorders. “Most physicians do not routinely test for vitamin D deficiency,” Penckofer said. “However, most experts would agree that adults at risk for heart disease and others who experience fatigue joint pain or depression should have their vitamin D levels measured.”
Pfizer drops application to switch Viagra to OTC
NEW YORK Pfizer has withdrawn its application to switch 50 mg Viagra tablets from prescription to OTC in the European Union, the drug maker announced Thursday.
The company said it considers Viagra a suitable candidate for OTC availability and meets the European Commission’s criteria for OTC switches.
However, in a letter to the European Medicines Agency, Pfizer said it would withdraw the application to fully consider comments from the EMEA’s Committee for Medicinal Products for Human Use, recognizing that there were concerns regarding the proposed supply of the tablets without prescription in the EU. Pfizer said the withdrawal would allow evaluation of further information and additional data that may be required to allow any future assessments.
“Viagra has a proven safety profile that has been well-established in extensive post-marketing studies and in more than 120 clinical trials,” Pfizer vice president of medical and regulatory affairs Rory O’Connor said in a statement. “We will continue to work with regulators in Europe to improve the availability of our medicines to patients and physicians and the benefits they get from our therapies.”